- Home
- VBIO vs IBG Comparison
VBIO vs IBG Comparison
Compare VBIO & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VBIO | IBG |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Australia |
| Employees | 52 | 9 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | VBIO | IBG |
|---|---|---|
| Price | $0.32 | $0.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 530.1K | 54.6K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $0.30 |
| 52 Week High | $0.61 | $6.50 |
Technical Indicators
Market Signals| Indicator | VBIO | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 36.73 | 44.43 |
| Support Level | $0.25 | $0.70 |
| Resistance Level | $0.51 | $1.28 |
| Average True Range (ATR) | 0.07 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 25.86 | 49.67 |
Price Performance
Historical ComparisonAbout VBIO Valion Bio Inc. Common Stock
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.